Inactivating MUTYH germline mutations in pediatric patients with high-grade midline gliomas

Cassie N Kline¹, Nancy M Joseph¹, James P Grenert¹+5

• ¹Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of California, San Francisco, California (C.N.K., S.M.); Clinical Cancer Genomics Laboratory, University of California, San Francisco, California (N.M.J., J.P.G., J.v.Z., I.Y., B.C.B.); Departments of Neurology and Neurosurgery, University of California, San Francisco, California (S.M.); Division of Neuropathology, Department of Pathology, University of California, San Francisco, California (D.A.S.).